JP2022539185A5 - - Google Patents
Info
- Publication number
- JP2022539185A5 JP2022539185A5 JP2021577642A JP2021577642A JP2022539185A5 JP 2022539185 A5 JP2022539185 A5 JP 2022539185A5 JP 2021577642 A JP2021577642 A JP 2021577642A JP 2021577642 A JP2021577642 A JP 2021577642A JP 2022539185 A5 JP2022539185 A5 JP 2022539185A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- nootropic
- acid
- compound
- nootropic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1909454.9A GB201909454D0 (en) | 2019-07-01 | 2019-07-01 | Enhancers |
| GB1909454.9 | 2019-07-01 | ||
| PCT/EP2020/068229 WO2021001306A1 (en) | 2019-07-01 | 2020-06-29 | Methylthioninium as enhancers of the cognitive function |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539185A JP2022539185A (ja) | 2022-09-07 |
| JP2022539185A5 true JP2022539185A5 (https=) | 2023-07-07 |
| JP7686581B2 JP7686581B2 (ja) | 2025-06-02 |
Family
ID=67539959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577642A Active JP7686581B2 (ja) | 2019-07-01 | 2020-06-29 | 認知機能の向上薬としてのメチルチオニニウム |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220330594A1 (https=) |
| EP (1) | EP3989977A1 (https=) |
| JP (1) | JP7686581B2 (https=) |
| KR (1) | KR20220028045A (https=) |
| CN (1) | CN114096254A (https=) |
| AU (1) | AU2020298737B2 (https=) |
| BR (1) | BR112021025330A2 (https=) |
| CA (1) | CA3143417A1 (https=) |
| GB (1) | GB201909454D0 (https=) |
| IL (1) | IL289341A (https=) |
| MX (1) | MX2021015289A (https=) |
| WO (1) | WO2021001306A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY148145A (en) | 2006-07-11 | 2013-03-15 | Wista Lab Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| FI4385512T3 (fi) | 2018-07-26 | 2026-01-12 | Taurx Therapeutics Man Ltd | Diaminofenotiatsiinien optimoitu annostus populaatioille |
| KR102856378B1 (ko) | 2022-09-30 | 2025-09-08 | 주식회사 젬백스앤카엘 | 4r 타우병증의 치료 또는 예방용 펩티드 |
| KR20250154422A (ko) | 2023-03-03 | 2025-10-28 | 타우알엑스 쎄라퓨틱스 매니지먼트 리미티드 | 미세혈관 뇌질환 치료를 위한 디아미노페노티아진 |
| KR20240176447A (ko) | 2023-06-15 | 2024-12-24 | 주식회사 젬백스앤카엘 | 신규 펩티드 및 이의 용도 |
| KR102800994B1 (ko) | 2023-11-06 | 2025-04-29 | 주식회사 엘지에너지솔루션 | 무음극 코팅층 및 이를 포함하는 전고체 전지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| ES2349322T7 (es) | 2006-03-29 | 2019-10-17 | Wista Lab Ltd | Sales de 3,7-diamino-10H-fenotiazina y su utilización |
| AU2008265045B2 (en) | 2007-06-19 | 2014-02-27 | Taurx Therapeutics Management Ltd. | Phenothiazine compounds for treating Mild Cognitive Impairment |
| CA2701075C (en) | 2007-10-03 | 2019-02-12 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines. |
| JP5898701B2 (ja) | 2011-02-11 | 2016-04-13 | ウィスタ ラボラトリーズ リミテッド | フェノチアジンジアミニウム塩およびそれらの使用 |
| EP2705841A1 (en) | 2012-09-05 | 2014-03-12 | Pharnext | Combinations of nootropic agents for treating cognitive dysfunctions |
| JP7073330B2 (ja) | 2016-07-25 | 2022-05-23 | ウィスタ ラボラトリーズ リミテッド | ジアミノフェノチアジンの投与及び投与量 |
| GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
-
2019
- 2019-07-01 GB GBGB1909454.9A patent/GB201909454D0/en not_active Ceased
-
2020
- 2020-06-29 AU AU2020298737A patent/AU2020298737B2/en active Active
- 2020-06-29 WO PCT/EP2020/068229 patent/WO2021001306A1/en not_active Ceased
- 2020-06-29 KR KR1020227003214A patent/KR20220028045A/ko not_active Ceased
- 2020-06-29 CA CA3143417A patent/CA3143417A1/en active Pending
- 2020-06-29 CN CN202080048926.1A patent/CN114096254A/zh active Pending
- 2020-06-29 BR BR112021025330A patent/BR112021025330A2/pt unknown
- 2020-06-29 EP EP20735367.3A patent/EP3989977A1/en active Pending
- 2020-06-29 JP JP2021577642A patent/JP7686581B2/ja active Active
- 2020-06-29 US US17/620,956 patent/US20220330594A1/en active Pending
- 2020-06-29 MX MX2021015289A patent/MX2021015289A/es unknown
-
2021
- 2021-12-23 IL IL289341A patent/IL289341A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022539185A5 (https=) | ||
| AU2020203101B9 (en) | Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability | |
| JP2020519661A5 (https=) | ||
| US10857118B2 (en) | Compositions and methods for treating intestinal hyperpermeability | |
| JP2022545005A5 (https=) | ||
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| ES2698363T3 (es) | Composiciones de oxprenolol para tratar el cáncer | |
| JP2023546565A5 (https=) | ||
| JP2009525265A5 (https=) | ||
| KR20120050473A (ko) | 탈수초성 질환 및 다른 신경계 질환을 앓는 환자에서 신경-인지 및/또는 신경-정신 손상을 개선하기 위한 4-아미노피리딘의 용도 | |
| JPWO2023054732A5 (https=) | ||
| JP2024520132A5 (https=) | ||
| JP2023504166A (ja) | 疼痛の治療のためのＫｖ７カリウムチャネル開口薬の使用 | |
| TW201902474A (zh) | 用於治療中風及減少神經損傷的化合物及其用途 | |
| KR20160067225A (ko) | 암 환자에서 근육 소모를 치료하는 선택적 안드로겐 수용체 조절물질 및 화학치료제 | |
| JP2002534379A5 (https=) | ||
| JP2023531930A5 (https=) | ||
| CN103002893B (zh) | 神经障碍性疼痛的治疗药或预防药 | |
| RU2017134553A (ru) | Хорошо растворимые в воде соли фенилалкиламина - быстродействующего блокатора кальциевых каналов, и их применение | |
| JP2022538642A5 (https=) | ||
| JP2023512093A (ja) | コロナウイルス感染の治療における４－アミノキノリン化合物の使用 | |
| JP2015526504A5 (https=) | ||
| JP2021091608A5 (https=) | ||
| WO2023066330A1 (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| US20160166565A1 (en) | Treatment of multiple sclerosis with combination of laquinimod and flupirtine |